Headlines

Arvinas, Pfizer Breast Cancer Drug Fails To Show Progression-Free Survival Benefit In Trial

Arvinas and Pfizer’s Phase 3 trial shows vepdegestrant significantly improves progression-free survival in breast cancer patients.

read more

Leave a Reply

Your email address will not be published. Required fields are marked *